Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
National Cancer Institute (NCI)
Karyopharm Therapeutics Inc
AstraZeneca
Institut du Cancer de Montpellier - Val d'Aurelle
AstraZeneca
Genmab
Northwestern University
Northwestern University
M.D. Anderson Cancer Center